Taiwan's Adimmune To Submit New H1N1 Vaccine Bid To Government
This article was originally published in PharmAsia News
Executive Summary
The biopharmaceutical outfit Adimmune says it expects to become the only supplier of an A/H1N1 vaccine in Taiwan despite a law that requires at least three companies bid for government orders. Adimmune submitted a bid to supply 5 million doses of an H1N1 vaccine to the Department of Health, but the tender failed because only Adimmune submitted a bid. The department said it would open a second tender this week, but would not require a minimum number of bidders or a preset price range, in line with an interpretation of the Government Procurement Act. An Adimmune spokesman said the firm would submit a new tender. (Click here for more